BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sisto M, Lisi S, Lofrumento DD, Ingravallo G, De Lucro R, D'Amore M. Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome. J Mol Histol 2013;44:447-54. [PMID: 23377923 DOI: 10.1007/s10735-013-9487-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Sisto M, Lorusso L, Lisi S. TLR2 signals via NF-κB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjögren's syndrome. Clin Exp Med 2017;17:341-50. [PMID: 27260411 DOI: 10.1007/s10238-016-0429-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
2 Voulgarelis M, Mavragani CP, Xu L, Treon SP, Moutsopoulos HM. Absence of somatic MYD88 L265P mutations in patients with primary Sjogren's syndrome. Genes Immun 2014;15:54-6. [PMID: 24153350 DOI: 10.1038/gene.2013.54] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Saito K, Mori S, Date F, Hong G. Epigallocatechin gallate stimulates the neuroreactive salivary secretomotor system in autoimmune sialadenitis of MRL-Fas(lpr) mice via activation of cAMP-dependent protein kinase A and inactivation of nuclear factor κB. Autoimmunity 2015;48:379-88. [PMID: 25847253 DOI: 10.3109/08916934.2015.1030617] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 Adelaja A, Taylor B, Sheu KM, Liu Y, Luecke S, Hoffmann A. Six distinct NFκB signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responses. Immunity 2021;54:916-930.e7. [PMID: 33979588 DOI: 10.1016/j.immuni.2021.04.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pringle S, Wang X, Bootsma H, Spijkervet FKL, Vissink A, Kroese FGM. Small-molecule inhibitors and the salivary gland epithelium in Sjögren's syndrome. Expert Opin Investig Drugs 2019;28:605-16. [PMID: 31203680 DOI: 10.1080/13543784.2019.1631796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
6 Sisto M, Barca A, Lofrumento DD, Lisi S. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20. Clin Exp Immunol 2016;184:183-96. [PMID: 26724675 DOI: 10.1111/cei.12764] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
7 Vakrakou AG, Polyzos A, Kapsogeorgou EK, Thanos D, Manoussakis MN. Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation. J Autoimmun 2018;86:62-74. [PMID: 29033144 DOI: 10.1016/j.jaut.2017.09.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
8 Sisto M, Ribatti D, Lisi S. Understanding the Complexity of Sjögren's Syndrome: Remarkable Progress in Elucidating NF-κB Mechanisms. J Clin Med 2020;9:E2821. [PMID: 32878252 DOI: 10.3390/jcm9092821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Sisto M, Lisi S, D'Amore M, Lofrumento DD. Rituximab-mediated Raf kinase inhibitor protein induction modulates NF-κB in Sjögren syndrome. Immunology 2014;143:42-51. [PMID: 24655025 DOI: 10.1111/imm.12288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]